Weed (BUDZ) Other Non-Current Assets (2010 - 2018)
Weed (BUDZ) recorded quarterly Other Non-Current Assets of $200400.0 in Q4 2018, up 1721.82% quarter-over-quarter from $11000.0 in Q1 2012.
Weed (BUDZ) Other Non-Current Assets (2010 - 2018) Analysis & Trends
Weed's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $200400.0 for Q4 2018.
- In Q4 2018, Other Non-Current Assets changed N/A year-over-year to $200400.0; the TTM figure through Dec 2018 stood at $200400.0 (changed N/A YoY), while the FY2018 annual figure was $200400.0, changed N/A from the prior year.
- Other Non-Current Assets was $200400.0 for Q4 2018 at Weed, up from $11000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $200400.0 in Q4 2018 to a low of $200400.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Weed | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 200,400.00 |
| Mar 31, 2012 | 11,000.00 |
| Dec 31, 2011 | 11,000.00 |
| Sep 30, 2011 | 11,000.00 |
| Jun 30, 2011 | 108,660.00 |
| Dec 31, 2010 | 111,500.00 |